Coapt is a neurotechnology company focused on improving prosthetic control through advanced myoelectric signal decoding. The company develops software that interprets muscle activation patterns to enable more natural and responsive control of upper-limb prostheses.

Its platform uses machine learning algorithms to continuously adapt to an individual user’s neuromuscular signals, allowing prosthetic devices to respond reliably across different positions, loads, and daily activities. This adaptive approach reduces training burden and improves usability compared with static pattern-recognition systems.

Coapt’s technology is deployed in clinical and rehabilitation settings and is compatible with a wide range of commercial prosthetic hardware. The company positions its software as an enabling control layer that enhances functional outcomes for people with limb loss rather than as a standalone medical device.